- Sections
- C - Chimie; métallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 317/40 - Y étant un atome d'hydrogène ou de carbone
Détention brevets de la classe C07C 317/40
Brevets de cette classe: 79
Historique des publications depuis 10 ans
15
|
5
|
10
|
7
|
5
|
2
|
3
|
6
|
4
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Corteva Agriscience LLC | 2681 |
9 |
Mitsui Chemicals, Inc. | 3187 |
4 |
Peloton Therapeutics, Inc. | 37 |
4 |
Northwestern University | 3276 |
3 |
The Scripps Research Institute | 1353 |
3 |
Syngenta Participations AG | 3032 |
2 |
Bayer Cropscience AG | 2138 |
2 |
Dow AgroSciences LLC | 1238 |
2 |
The General Hospital Corporation | 4650 |
2 |
Battelle Memorial Institute | 2419 |
2 |
Adeka Corporation | 1342 |
2 |
Dana-Farber Cancer Institute, Inc. | 2535 |
2 |
Flexus Biosciences, Inc. | 13 |
2 |
The Florida International University Board of Trustees | 582 |
2 |
Merck Canada Inc. | 89 |
2 |
Nihon Nohyaku Co., Ltd. | 315 |
2 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
2 |
Metrion Biosciences Limited | 10 |
2 |
Bristol-myers Squibb Company | 4863 |
1 |
F. Hoffmann-La Roche AG | 7942 |
1 |
Autres propriétaires | 28 |